ICD-10-CM Code D07.39

Carcinoma in situ of other female genital organs

Version 2020 Billable Code Diagnoses For Females Only Neoplasm CaInSitu

Valid for Submission

D07.39 is a billable code used to specify a medical diagnosis of carcinoma in situ of other female genital organs. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code D07.39 might also be used to specify conditions or terms like carcinoma in situ of broad ligament, carcinoma in situ of fallopian tube, carcinoma in situ of ovary, carcinoma in situ of parametrium, carcinoma in situ of round ligament of uterus, carcinoma in situ of uterine adnexa, etc

The code D07.39 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: adnexa (uterine) ; broad ligament ; corpus ; corpus albicans ; fallopian tube (accessory) ; genital organ or tract female NEC specified site NEC ; ligament [See Also: Neoplasm, connective tissue] ; etc

ICD-10:D07.39
Short Description:Carcinoma in situ of other female genital organs
Long Description:Carcinoma in situ of other female genital organs

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

  • Diagnoses for females only - Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, this code applies to FEMALES only .

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Carcinoma in situ of broad ligament
  • Carcinoma in situ of fallopian tube
  • Carcinoma in situ of ovary
  • Carcinoma in situ of parametrium
  • Carcinoma in situ of round ligament of uterus
  • Carcinoma in situ of uterine adnexa
  • Neoplasm of round ligament of uterus
  • Tis

Diagnostic Related Groups

The ICD-10 code D07.39 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
  • 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
  • 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
  • 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
  • 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
  • 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC

Convert D07.39 to ICD-9

  • 233.39 - Ca in situ fem gen NEC (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of other and unspecified genital organs (D07)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code D07.39 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»adnexa (uterine)
C57.4C79.89D07.39D28.7D39.8D49.59
»broad ligament
C57.1C79.82D07.39D28.2D39.8D49.59
»corpus
C56.C79.6D07.39D27.D39.1D49.59
»corpus
  »albicans
C56.C79.6D07.39D27.D39.1D49.59
»fallopian tube (accessory)
C57.0C79.82D07.39D28.2D39.8D49.59
»genital organ or tract
  »female NEC
    »specified site NEC
C57.7C79.82D07.39D28.7D39.8D49.59
»ligament [See Also: Neoplasm, connective tissue]
C57.1C79.82D07.39D28.2D39.8D49.59
»ligament [See Also: Neoplasm, connective tissue]
  »broad
C57.1C79.82D07.39D28.2D39.8D49.59
»ligament [See Also: Neoplasm, connective tissue]
  »Mackenrodt's
C57.7C79.82D07.39D28.7D39.8D49.59
»ligament [See Also: Neoplasm, connective tissue]
  »utero-ovarian
C57.7C79.82D07.39D28.2D39.8D49.59
»Mackenrodt's ligament
C57.7C79.82D07.39D28.7D39.8D49.59
»mesosalpinx
C57.1C79.82D07.39D28.2D39.8D49.59
»mesovarium
C57.1C79.82D07.39D28.2D39.8D49.59
»Mullerian duct
C57.7C79.82D07.39D28.7D39.8D49.59
»Mullerian duct
  »female
C57.7C79.82D07.39D28.7D39.8D49.59
»ovary
C56.C79.6D07.39D27.D39.1D49.59
»oviduct
C57.0C79.82D07.39D28.2D39.8D49.59
»paroophoron
C57.1C79.82D07.39D28.2D39.8D49.59
»parovarium
C57.1C79.82D07.39D28.2D39.8D49.59
»salpinx (uterine)
C57.0C79.82D07.39D28.2D39.8D49.59
»tubo-ovarian
C57.8C79.82D07.39D28.7D39.8D49.59
»utero-ovarian
C57.8C79.82D07.39D28.7D39.8D49.59
»utero-ovarian
  »ligament
C57.1C79.82D07.39D28.2D39.8D49.59
»uterus, uteri, uterine
  »adnexa NEC
C57.4C79.82D07.39D28.7D39.8D49.59
»uterus, uteri, uterine
  »ligament
    »broad
C57.1C79.82D07.39D28.2D39.8D49.59
»uterus, uteri, uterine
  »tube
C57.0C79.82D07.39D28.2D39.8D49.59
»wolffian (body) (duct)
C57.7C79.82D07.39D28.7D39.8D49.59
»wolffian (body) (duct)
  »female
C57.7C79.82D07.39D28.7D39.8D49.59

Information for Patients


Cancer

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute


[Learn More]